Skip to main content
. 2020 Nov 17;4:63. doi: 10.1186/s41747-020-00190-1

Fig. 2.

Fig. 2

A patient example with pseudoprogression of diffuse large B cell lymphoma undergoing chimeric antigen receptor T (CAR-T) cell therapy. Eight weeks after reinfusion of CAR-T cells, numerous abdominal lymph nodes with highly increased metabolism occurred, but fully resolved in the further disease course without additional treatment